KELLECİ ÇAKIR, B. Et Al. 2021. Benefit versus toxicity risk of digoxin in patients with COVID-19. EUROPEAN JOURNAL OF HOSPITAL PHARMACY , vol.29, no.6 .

KELLECİ ÇAKIR, B., Bayraktar-Ekincioglu, A., & Demirkan, K., (2021). Benefit versus toxicity risk of digoxin in patients with COVID-19. EUROPEAN JOURNAL OF HOSPITAL PHARMACY , vol.29, no.6.

KELLECİ ÇAKIR, BURCU, SALİH KUTAY DEMİRKAN, And Kutay Demirkan. "Benefit versus toxicity risk of digoxin in patients with COVID-19," EUROPEAN JOURNAL OF HOSPITAL PHARMACY , vol.29, no.6, 2021

KELLECİ ÇAKIR, BURCU K. Et Al. "Benefit versus toxicity risk of digoxin in patients with COVID-19." EUROPEAN JOURNAL OF HOSPITAL PHARMACY , vol.29, no.6, 2021

KELLECİ ÇAKIR, B. Bayraktar-Ekincioglu, A. And Demirkan, K. (2021) . "Benefit versus toxicity risk of digoxin in patients with COVID-19." EUROPEAN JOURNAL OF HOSPITAL PHARMACY , vol.29, no.6.

@article{article, author={BURCU KELLECİ ÇAKIR Et Al. }, title={Benefit versus toxicity risk of digoxin in patients with COVID-19}, journal={EUROPEAN JOURNAL OF HOSPITAL PHARMACY}, year=2021}